Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Guan, Kaomei  [Clear All Filters]
2024
Schmidt S, Li W, Schubert M, Binnewerg B, Prönnecke C, Zitzmann FD, Bulst M, Wegner S, Meier M, Guan K, et al. Novel high-dense microelectrode array based multimodal bioelectronic monitoring system for cardiac arrhythmia re-entry analysis. Biosens Bioelectron. 2024;252:116120.
2023
Oeing CU, Pepin ME, Saul KB, Agircan ASeyhan, Assenov Y, Merkel TS, Sedaghat-Hamedani F, Weis T, Meder B, Guan K, et al. Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure. Basic Res Cardiol. 2023;118(1):9.
2022
Poetsch MS, Strano A, Guan K. Human induced pluripotent stem cells: From cell origin, genomic stability and epigenetic memory to translational medicine. Stem Cells. 2022.
2021
Li W, Luo X, Ulbricht Y, Guan K. Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study. Stem Cell Res. 2021;56:102565.
2020
Li W, Stauske M, Luo X, Wagner S, Vollrath M, Mehnert CS, Schubert M, Cyganek L, Chen S, Hasheminasab S-M, et al. Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation. Front Cell Dev Biol. 2020;8:592893.
2019
Kolanowski TJan, Busek M, Schubert M, Dmitrieva A, Binnewerg B, Pöche J, Fisher K, Schmieder F, Grünzner S, Hansen S, et al. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system. Acta Biomater. 2019.
Li W, Luo X, Ulbricht Y, Wagner M, Piorkowski C, El-Armouche A, Guan K. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs. Stem Cell Res. 2019;41:101662.
2015
Kruse V, Hamann C, Monecke S, Cyganek L, Elsner L, Hübscher D, Walter L, Streckfuss-Bömeke K, Guan K, Dressel R. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1. PLoS One. 2015;10(5):e0125544.